BMJ Open Respiratory Research (May 2020)

Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure

  • Rohit Gupta,
  • Andrew Gangemi,
  • Huaqing Zhao,
  • Maulin Patel,
  • Robert Marron,
  • Junad Chowdhury,
  • Ibraheem Yousef,
  • Matthew Zheng,
  • Nicole Mills,
  • Lauren Tragesser,
  • Julie Giurintano,
  • Matthew Gordon,
  • Parth Rali,
  • Gilbert D'Alonso,
  • Nicole Patlakh

DOI
https://doi.org/10.1136/bmjresp-2020-000650
Journal volume & issue
Vol. 7, no. 1

Abstract

Read online

Conclusion HFNT use is associated with a reduction in the rate of invasive mechanical ventilation and overall mortality in patients with COVID-19 infection.